1. Home
  2. EDSA vs DTSS Comparison

EDSA vs DTSS Comparison

Compare EDSA & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • DTSS
  • Stock Information
  • Founded
  • EDSA 2015
  • DTSS 2014
  • Country
  • EDSA Canada
  • DTSS China
  • Employees
  • EDSA N/A
  • DTSS N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • DTSS Computer Software: Prepackaged Software
  • Sector
  • EDSA Health Care
  • DTSS Technology
  • Exchange
  • EDSA Nasdaq
  • DTSS Nasdaq
  • Market Cap
  • EDSA 15.9M
  • DTSS 16.5M
  • IPO Year
  • EDSA N/A
  • DTSS N/A
  • Fundamental
  • Price
  • EDSA $2.11
  • DTSS $1.84
  • Analyst Decision
  • EDSA Strong Buy
  • DTSS
  • Analyst Count
  • EDSA 2
  • DTSS 0
  • Target Price
  • EDSA $13.00
  • DTSS N/A
  • AVG Volume (30 Days)
  • EDSA 38.0K
  • DTSS 57.0K
  • Earning Date
  • EDSA 08-08-2025
  • DTSS 09-25-2025
  • Dividend Yield
  • EDSA N/A
  • DTSS N/A
  • EPS Growth
  • EDSA N/A
  • DTSS N/A
  • EPS
  • EDSA N/A
  • DTSS N/A
  • Revenue
  • EDSA N/A
  • DTSS $56,255,129.00
  • Revenue This Year
  • EDSA N/A
  • DTSS N/A
  • Revenue Next Year
  • EDSA N/A
  • DTSS N/A
  • P/E Ratio
  • EDSA N/A
  • DTSS N/A
  • Revenue Growth
  • EDSA N/A
  • DTSS 144.20
  • 52 Week Low
  • EDSA $1.55
  • DTSS $1.63
  • 52 Week High
  • EDSA $5.18
  • DTSS $3.55
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 42.63
  • DTSS 38.15
  • Support Level
  • EDSA $2.02
  • DTSS $1.80
  • Resistance Level
  • EDSA $2.35
  • DTSS $1.99
  • Average True Range (ATR)
  • EDSA 0.14
  • DTSS 0.10
  • MACD
  • EDSA -0.03
  • DTSS -0.02
  • Stochastic Oscillator
  • EDSA 18.00
  • DTSS 10.70

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About DTSS Datasea Inc.

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Share on Social Networks: